CHAPTER 1 INTRODUCTION
1.1. KEY BENEFITS
1.2. KEY MARKET SEGMENTS
1.3. KEY PLAYERS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. Rising incidence of sudden cardiac arrest (SCA)
3.3.1.2. Technologically advanced implantable defibrillators
3.3.1.3. Presence of high unmet medical needs
3.3.2. Restraints
3.3.2.1. Limited insurance coverage
3.3.2.2. Presence of alternative mode of treatment
3.3.3. Opportunities
3.3.3.1. Lucrative opportunities in emerging economies
CHAPTER 4 IMPLANTABLE DEFIBRILLATORS MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.1.3. Market size and forecast
4.2. SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDS)
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. TRANSVENOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (T-ICDS)
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D)
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 IMPLANTABLE DEFIBRILLATORS MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast by Country
5.2.4. Market size and forecast by Product
5.2.4.1. U.S. market size and forecast
5.2.4.2. Canada market size and forecast
5.2.4.3. Mexico market size and forecast
5.3. EUROPE
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast by Country
5.3.4. Market size and forecast by Product
5.3.4.1. UK market size and forecast
5.3.4.2. Germany market size and forecast
5.3.4.3. France market size and forecast
5.3.4.4. Italy market size and forecast
5.3.4.5. Spain market size and forecast
5.3.4.6. Rest of Europe market size and forecast
5.4. ASIA-PACIFIC
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast by Country
5.4.4. Market size and forecast by Product
5.4.4.1. Japan market size and forecast
5.4.4.2. India market size and forecast
5.4.4.3. China market size and forecast
5.4.4.4. Australia market size and forecast
5.4.4.5. Rest of Asia-Pacific market size and forecast
5.5. LAMEA
5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast by Country
5.5.4. Market size and forecast by Product
5.5.4.1. Brazil market size and forecast
5.5.4.2. Argentina market size and forecast
5.5.4.3. Egypt market size and forecast
5.5.4.4. Israel market size and forecast
5.5.4.5. South Africa market size and forecast
5.5.4.6. Rest of LAMEA market size and forecast
CHAPTER 6 COMPANY PROFILES
6.1. BOSTON SCIENTIFIC CORPORATION
6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments
6.2. LIVANOVA PLC COMPANY
6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments
6.3. IMRICOR MEDICAL SYSTEMS
6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments
6.4. MICROPORT SCIENTIFIC CORPORATION
6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments
6.5. MAYO CLINIC US
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments
6.6. MEDTRONIC PLC
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments
6.7. MRI INTERVENTIONS, INC.
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments
6.8. ST. JUDE MEDICAL, INC.
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments
6.9. BIOTRONIK SE & CO.KG
6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments
6.10. SORIN GROUP
6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments